MiscellaneousEvotec receives grant from Korean Government to develop novel antibody-based treatments for lung diseases 22.01.2025 / 07:30 CET/CESTThe issuer is solely responsible for the content of ...

School administrators and nurses are encouraged to review applicable state laws and regulations to ensure neffy® (epinephrine ...

Northwell Health’s Feinstein Institutes for Medical Research has received a $2.9m grant from the NIH to explore the use of ...

The FDA has narrowly beaten the European Medicines Agency (EMA) to the most approved drugs with a new active substance in ...

Sun Pharma is set to release its Q3 earnings on January 31, 2024, potentially declaring an interim dividend. The company reported a 28% increase in net profit to ₹3,040 crore for the September ...

Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 47.40% ...

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Kura Oncology (KURA – Research Report) and ARS ...

ARS Pharmaceuticals, Inc. (NASDAQ:SPRY – Get Free Report) shares gapped up before the market opened on Tuesday after Raymond James raised their price target on the stock from $26.00 to $28.00. The ...

In a report released today, Ryan Deschner from Raymond James maintained a Buy rating on ARS Pharmaceuticals (SPRY – Research Report), with a ...

Biotech stocks put up a split showing at JPM, where names like BridgeBio, ARS and Harmony stood out with strong preliminary ...

Preliminary cash, cash equivalents and short-term investments of $314.0 million at year-end 2024 to support an operating runway of at least three years Company to present at 43 rd Annual J.P. Morgan ...

ARS Pharmaceuticals' stock experienced a significant rise, peaking at an 11% increase, marking the largest intraday leap since August. This surge was prompted by the company's announcement of its ...